Featured Question

How would you approach the management of a patient with T2DM having problems with multiple combinational pills and experiencing erratic glucose control? Would the GLP-1–based therapies have any benefits in such patients?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities

10-17-2014

Challenging Cases in Advanced Prostate Cancer: Expert Guidance on Selection and Sequencing of the Latest Therapies

Course Director
Oliver Sartor, MD
Tulane Cancer Center
Tulane University School of Medicine
New Orleans, Louisiana

10-02-2014

Latest Imaging Tools for Assessing the Disease Course of Patients With Multiple Sclerosis

Course Director
Matilde Inglese, MD, PhD
Icahn School of Medicine at
Mount Sinai
New York, New York

09-19-2014

Assessing the Evolving Therapeutic Landscape in Advanced Prostate Cancer: Where Do We Stand?

Course Director
Oliver Sartor, MD
Tulane Cancer Center
Tulane University School of Medicine
New Orleans, Louisiana

03-15-2013

Challenging Cases in Multiple Sclerosis

Course Director
Aaron E. Miller, MD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York